Share-Based Compensation (Stock Appreciation Rights Activity) (Details)	9 Months Ended
	Oct. 29, 2022 USD ($) $ / shares shares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $	$ 1,757,000
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021 | shares	236,139
Number of Underlying Shares, Forfeited | shares	(37,800)
Number of Underlying Shares, Ending Balance at July 31, 2021 | shares	198,339
Number of Underlying shares, Stock appreciation rights exercisable | shares	198,339
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2021 | $ / shares	$ 32.55
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	48.72
Weighted-Average Grant Date Fair Value, Ending Balance at July 31, 2021 | $ / shares	29.47
Weighted-Average Exercise Price, Stock appreciation rights exercisable | $ / shares	$ 29.47
Aggregate Intrinsic Value, Outstanding | $	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable | $	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	1 year 10 months 24 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	1 year 10 months 24 days